This study looks at a new treatment called SBT777101 for people with rheumatoid arthritis (RA), a disease that causes joint pain and swelling. The study examines if the treatment is safe when given in different doses. This therapy uses the patient's own cells to help reduce inflammation and balance the immune system. Participants in this study need to be adults with moderate-to-severe RA and must have tried other RA treatments without much success. The study will require a joint biopsy, which is a small sample taken from the joint to check for inflammation. It is important to note that if you have other major health issues, infections, or a history of other joint diseases, you might not qualify for this study.

• Study involves a single dose treatment and joint biopsy.
• Participants must have stable RA medication for at least 30 days.
• Effective contraception is necessary during the study.

Make sure to consider these points and discuss with your doctor if this study might be a good fit for you. 😊